Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!
Aug 05, 2019
Failure in suppressing epilepsy; steps away from seizure-freedom Epilepsy, a central nervous system disorder that hinders the normal functioning of the brain, and leads to abnormality and loss of awareness. It affects over 70 million people worldwide, wherein nearly a quarter of patients with seizures have drug-...
Read More...
Jun 11, 2019
Lilly tests the efficacy of Tirzepatide-a novel dual GIP, GLP-1 agonist Eli Lilly is planning to test its diabetes drug Tirzepatide in a phase 2b Non-Alcoholic Steatohepatitis (NASH) trial. Tirzepatide, also known as LY3298176, has been excellent in reducing body weight and blood sugar in patients with poorly co...
Read More...
Mar 26, 2019
World Epilepsy Day This World EPILEPSY Day fight to #endepilepsy. Educate people about epilepsy and raise awareness. #AimForZero. Turn purple for #purpleday.
Read More...
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Transforming Multiple Myeloma Treatment: The Promise of Novel Drug Classes
Jul 24, 2024
Newsletter/Whitepaper